Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Eisai Korea Inc.

Clinical trials sponsored by Eisai Korea Inc., explained in plain language.

Now part of Eisai Co., Ltd. 4523 TOKYO

The Korean subsidiary of Eisai, a Japanese pharmaceutical company.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

New hope for arthritis sufferers: filgotinib shows promise in korean trial

Disease control Completed

This study tested the drug filgotinib (Jyseleca) in 118 Korean adults with rheumatoid arthritis. The goal was to see how many patients experienced at least a 20% improvement in symptoms after 12 weeks of treatment. The trial is complete, and results will help determine if filgoti…

Phase: PHASE4 • Sponsor: Eisai Korea Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:31 UTC